Sanara MedTech
SMTI
Market cap $271M

30.99 USD

-0.31

0.99%

At close Oct 17, 4:00 PM EDT

1 day

-0.99%

5 days

-2.18%

1 month

-5.08%

3 months

2.96%

6 months

-1.93%

Year to date

-24.30%

1 year

2.04%

5 years

10.01%

About: Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Employees: 108

Healthcare Orthopedic, Prosthetic & Surgical Appliances & Supplies

0

Funds holding %

of 6,740 funds

–

Analysts bullish %

Fund manager confidence

Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)

100% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 10

0.49% more ownership

Funds ownership: 7.98% [Q1] → 8.46% (+0.49%) [Q2]

7% less funds holding

Funds holding: 43 [Q1] → 40 (-3) [Q2]

19% less capital invested

Capital invested by funds: $25.4M [Q1] → $20.6M (-$4.83M) [Q2]

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

See Fund Rankings

Research analyst outlook

We haven’t received any recent analyst ratings for SMTI.

See Analyst Rankings

Financial journalist opinion

Sanara MedTech Inc. Announces Changes to Its Board of Directors

FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets announced today changes to its Board of Directors (“Board”). After a long tenure of service with the predecessor company and Sanara, Mr. James “Jim” Stuckert has resigned from his position as a director, and Mr. Keith Myers has been appointed to serve as a director on the Board in order to fill the vacancy resulting from Mr. Stuckert's resignation. Mr. Stuckert will continue to serve the Board as Director Emeritus.

Sanara MedTech Inc. Announces Changes to Its Board of Directors

Sanara MedTech Inc (SMTI) Trading 3.79% Higher on Oct 2

Shares of Sanara MedTech Inc (SMTI, Financial) surged 3.79% in mid-day trading on Oct 2. The stock reached an intraday high of $30.10, up from its previous close of $29.00.

Sanara MedTech Inc (SMTI) Trading 3.79% Higher on Oct 2

Zacks Investment Research

Sanara Stock Gains From New US Distribution Deal With ChemoMouthPiece

SMTI, along with InfuSystem, inked a U.S. distribution agreement with ChemoMouthpiece. Under the agreement, ChemoMouthpiece's oral cryotherapy device will be distributed in cancer centers.

Sanara Stock Gains From New US Distribution Deal With ChemoMouthPiece

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

FORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem, Inc. (“InfuSystem”), the operational subsidiary of Sanara's joint venture partner InfuSystem Holdings, Inc., announced today the execution of an exclusive United States distribution agreement with, and minority investment in, ChemoMouthpiece, LLC (“ChemoMouthpiece”).

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

Sanara MedTech Inc. (SMTI) Q2 2024 Earnings Call Transcript

Sanara MedTech Inc. (SMTI) Q2 2024 Earnings Call Transcript

Sanara MedTech Inc. (SMTI) Q2 2024 Earnings Call Transcript

Sanara MedTech Inc. Announces Second Quarter 2024 Results

FORT WORTH, TX, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter ended June 30, 2024.

Sanara MedTech Inc. Announces Second Quarter 2024 Results

Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates

FORT WORTH, TX, July 30, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended June 30, 2024.

Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates

Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript

Sanara MedTech Inc. (NASDAQ:SMTI ) Q1 2024 Earnings Conference Call May 14, 2024 9:00 AM ET Company Participants Callon Nichols - Director of IR Ron Nixon - Executive Chairman Mike McNeil - CFO Seth Yon - President, Commercial Conference Call Participants Ian Cassel - IFCM Operator Greetings, welcome to the Sanara MedTech Inc. First Quarter Results and Business Update Conference Call. At this time all participants are in a listen-only mode.

Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript

Sanara MedTech Inc. Announces First Quarter 2024 Results

FORT WORTH, TX, May 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter ended March 31, 2024.

Sanara MedTech Inc. Announces First Quarter 2024 Results

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

FORT WORTH, TX, April 29, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended March 31, 2024.

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

See News Rankings

Charts implemented using Lightweight Charts™